Nokea
Which of the following conditions is not treated with epinephrine?
- A. Renal disease
- B. Asthma
- C. Hypotension
- D. Glaucoma
Correct Answer: A
Rationale: The correct answer is A: Renal disease. Epinephrine is not used to treat renal disease because it can potentially worsen kidney function. Epinephrine is used in asthma to dilate the airways, in hypotension to increase blood pressure, and in glaucoma to reduce intraocular pressure. Treating renal disease with epinephrine can lead to further complications due to its effect on blood flow and kidney function. Therefore, renal disease is not treated with epinephrine to avoid exacerbating kidney issues.
You may also like to solve these questions
Which of the following is not a side effect of loop diuretics?
- A. Alkalosis
- B. Nausea
- C. Hypotension
- D. Potassium deficits
Correct Answer: B
Rationale: The correct answer is B: Nausea. Loop diuretics like furosemide work by inhibiting the reabsorption of sodium and water in the loop of Henle in the kidneys. This mechanism can lead to electrolyte imbalances, such as potassium deficits (choice D), and volume depletion, resulting in hypotension (choice C). Loop diuretics can also cause metabolic alkalosis (choice A) due to loss of hydrogen ions. Nausea, however, is not a common side effect of loop diuretics. Therefore, choice B is not a side effect of loop diuretics, making it the correct answer.
Which of the following is classified as a class IA Sodium Channel blocker?
- A. Quinidine
- B. Disopyramide
- C. Aminodarone
- D. Propafenone
Correct Answer: A
Rationale: The correct answer is A: Quinidine. Quinidine is a class IA antiarrhythmic drug that blocks sodium channels in a use-dependent manner, which means it preferentially blocks channels that are open or have a rapid firing rate during depolarization. This action results in a decrease in conduction velocity and refractory period. Disopyramide is a class IA antiarrhythmic but does not specifically block sodium channels. Amiodarone is a class III antiarrhythmic that primarily affects potassium channels. Propafenone is a class IC antiarrhythmic that has minimal effects on sodium channel blockade. Therefore, Quinidine is the correct choice as a class IA sodium channel blocker.
Which of the following conditions is not treated with Lansoprazole?
- A. Zollinger-Ellison syndrome
- B. Gastritis
- C. Hypertension
- D. Reflux
Correct Answer: C
Rationale: Rationale: Lansoprazole is a proton pump inhibitor used to reduce stomach acid production. Hypertension is a condition related to high blood pressure and is not treated with Lansoprazole. Zollinger-Ellison syndrome, gastritis, and reflux are all conditions that can be treated with Lansoprazole due to its ability to reduce stomach acid. Therefore, choice C is the correct answer.
Which of the following is not a side effect of the cholinoreceptor blocker (Atropine)?
- A. Increased pulse
- B. Diarrhea
- C. Constipation
- D. Mydriasis
Correct Answer: B
Rationale: The correct answer is B: Diarrhea. Atropine, a cholinoreceptor blocker, inhibits acetylcholine, causing decreased GI motility leading to constipation. Atropine also increases pulse rate due to reduced vagal tone (A). It causes mydriasis by blocking cholinergic receptors in the eye (D). Diarrhea is not a typical side effect of atropine due to its anticholinergic properties.
Which of the following is not a side effect of the ACE Inhibitor (Captopril)?
- A. Rash
- B. Angioedema
- C. Cough
- D. Congestion
Correct Answer: D
Rationale: The correct answer is D: Congestion. ACE Inhibitors like Captopril do not typically cause congestion as a side effect. The main reason is that ACE inhibitors work by dilating blood vessels, which helps reduce blood pressure and improve blood flow. Congestion is more commonly associated with conditions like allergies or upper respiratory infections.
A: Rash - Possible side effect of ACE inhibitors, but not specific to Captopril.
B: Angioedema - Rare but serious side effect of ACE inhibitors, including Captopril.
C: Cough - Common side effect of ACE inhibitors due to increased bradykinin levels.